Cargando…

Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis

Many factors are involved in Alzheimer’s disease (AD) pathology including tau phosphorylation, amyloid β protein (Aβ) accumulation, lipid dysregulation, oxidative stress, and inflammation. The markers of these pathological processes in cerebral spinal fluid are used currently for AD diagnosis. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Rani, Palaniswamy, Krishnan, Sreeram, Rani Cathrine, Chellappa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509803/
https://www.ncbi.nlm.nih.gov/pubmed/28769864
http://dx.doi.org/10.3389/fneur.2017.00328
_version_ 1783250078491738112
author Rani, Palaniswamy
Krishnan, Sreeram
Rani Cathrine, Chellappa
author_facet Rani, Palaniswamy
Krishnan, Sreeram
Rani Cathrine, Chellappa
author_sort Rani, Palaniswamy
collection PubMed
description Many factors are involved in Alzheimer’s disease (AD) pathology including tau phosphorylation, amyloid β protein (Aβ) accumulation, lipid dysregulation, oxidative stress, and inflammation. The markers of these pathological processes in cerebral spinal fluid are used currently for AD diagnosis. However, peripheral biomarkers are the need of the hour for large population screening for AD. The main objective of the present study is to evaluate the peripheral levels of redox markers, lipid peroxidation (LPO) indicators, and pathological markers in AD patients. Blood was collected from AD patients (n = 45), controls (n = 45), and analyzed for pathological markers of AD including Aβ42 and tau, LPO, and redox indicators. Plasma Aβ42 was significantly (P < 0.001) elevated while total tau was decreased in AD compared to controls. Hydroxynonenal (HNE) and malondialdehyde (MDA) were higher (P < 0.001) in AD patients pointing the enhanced LPO in AD pathology. Receiver operating characteristic curve (ROC) analysis indicated that HNE is a better indicator of LPO compared to MDA. Plasma glutathione (GSH) level was significantly (P < 0.001) low while oxidized glutathione (GSSG) level was higher (P < 0.001) in AD patients with corresponding decrease in GSH/GSSG ratio (P < 0.001). ROC analysis indicated that GSH/GSSG ratio can be used as reliable indicator for redox imbalance in AD with a cutoff value of <8.73 (sensitivity 91.1%, specificity 97.8%). Correlation analysis revealed a positive correlation for both HNE and MDA with Aβ42 and a negative correlation with total tau. Negative correlation was observed between GSH/GSSG ratio and LPO markers. While oxidative stress has been implicated in pathology of various neurodegenerative disorders, the present study pinpoints the direct link between LPO and Aβ production in plasma of AD patients. Normally, at low amyloid concentration in body fluids, this peptide shown to function as a strong metal chelating antioxidant. However, when the Aβ production enhanced as in AD, through gain of functional transformation, Aβ evolves into prooxidant, thereby enhancing oxidative stress and LPO. Altered redox status with enhanced LPO observed in AD blood could contribute to the oxidation and S-glutathionylation proteins, which has to be addressed in future studies.
format Online
Article
Text
id pubmed-5509803
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-55098032017-08-02 Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis Rani, Palaniswamy Krishnan, Sreeram Rani Cathrine, Chellappa Front Neurol Neuroscience Many factors are involved in Alzheimer’s disease (AD) pathology including tau phosphorylation, amyloid β protein (Aβ) accumulation, lipid dysregulation, oxidative stress, and inflammation. The markers of these pathological processes in cerebral spinal fluid are used currently for AD diagnosis. However, peripheral biomarkers are the need of the hour for large population screening for AD. The main objective of the present study is to evaluate the peripheral levels of redox markers, lipid peroxidation (LPO) indicators, and pathological markers in AD patients. Blood was collected from AD patients (n = 45), controls (n = 45), and analyzed for pathological markers of AD including Aβ42 and tau, LPO, and redox indicators. Plasma Aβ42 was significantly (P < 0.001) elevated while total tau was decreased in AD compared to controls. Hydroxynonenal (HNE) and malondialdehyde (MDA) were higher (P < 0.001) in AD patients pointing the enhanced LPO in AD pathology. Receiver operating characteristic curve (ROC) analysis indicated that HNE is a better indicator of LPO compared to MDA. Plasma glutathione (GSH) level was significantly (P < 0.001) low while oxidized glutathione (GSSG) level was higher (P < 0.001) in AD patients with corresponding decrease in GSH/GSSG ratio (P < 0.001). ROC analysis indicated that GSH/GSSG ratio can be used as reliable indicator for redox imbalance in AD with a cutoff value of <8.73 (sensitivity 91.1%, specificity 97.8%). Correlation analysis revealed a positive correlation for both HNE and MDA with Aβ42 and a negative correlation with total tau. Negative correlation was observed between GSH/GSSG ratio and LPO markers. While oxidative stress has been implicated in pathology of various neurodegenerative disorders, the present study pinpoints the direct link between LPO and Aβ production in plasma of AD patients. Normally, at low amyloid concentration in body fluids, this peptide shown to function as a strong metal chelating antioxidant. However, when the Aβ production enhanced as in AD, through gain of functional transformation, Aβ evolves into prooxidant, thereby enhancing oxidative stress and LPO. Altered redox status with enhanced LPO observed in AD blood could contribute to the oxidation and S-glutathionylation proteins, which has to be addressed in future studies. Frontiers Media S.A. 2017-07-14 /pmc/articles/PMC5509803/ /pubmed/28769864 http://dx.doi.org/10.3389/fneur.2017.00328 Text en Copyright © 2017 Rani, Krishnan and Rani Cathrine. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Rani, Palaniswamy
Krishnan, Sreeram
Rani Cathrine, Chellappa
Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis
title Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis
title_full Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis
title_fullStr Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis
title_full_unstemmed Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis
title_short Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis
title_sort study on analysis of peripheral biomarkers for alzheimer’s disease diagnosis
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509803/
https://www.ncbi.nlm.nih.gov/pubmed/28769864
http://dx.doi.org/10.3389/fneur.2017.00328
work_keys_str_mv AT ranipalaniswamy studyonanalysisofperipheralbiomarkersforalzheimersdiseasediagnosis
AT krishnansreeram studyonanalysisofperipheralbiomarkersforalzheimersdiseasediagnosis
AT ranicathrinechellappa studyonanalysisofperipheralbiomarkersforalzheimersdiseasediagnosis